Health

Medicare copays for new Alzheimer’s drug could reach $11,500

A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

The drug, called Aduhelm, was approved by the Food and Drug Administration this week and quickly sparked controversy over its price and questionable benefits.

It’s the first Alzheimer’s medication in nearly 20 years, though it doesn’t cure the life-sapping…


Click here to view the original article.

Show More

Related Articles

Back to top button